C O V E R S T O R Y


Striking back

Will big pharma’s antidote to the COVID-19 waiver work?


Chinese remedy

What changes to China’s patent laws mean for life sciences


Mexico’s new IP regime

Will there be hurdles for plant owners?


NHS v Servier

Why the legal saga rumbles on


Exceptions in the UK

The low-down on experimental use exemptions


and much more…